RTTNews·2025-11-19 04:44Core Insights - Several small-cap biotech and pharma companies experienced notable gains in after-hours trading, with Nutex Health being the most significant mover following its quarterly results [1] Company Summaries - Nutex Health Inc. (NUTX): The company saw its stock surge by 20.97% to $120.00 after reporting a third-quarter net loss of $17.7 million, compared to a net loss of $0.4 million in the same period last year. However, total revenue increased significantly by 220.7% year-over-year to $244.0 million from $76.1 million [2] - Bullfrog AI Holdings, Inc. (BFRG): The stock rose by 5.87% to $0.9798 in after-hours trading, likely due to investor positioning ahead of an upcoming technical presentation at the AI Drug Discovery & Development Summit 2025 [3] - Clearside Biomedical, Inc. (CLSD): The company’s stock increased by 6.51% to $3.27 after reporting a narrower third-quarter net loss of $5.97 million compared to $7.69 million last year, although revenue fell sharply to $201 thousand from $1.04 million [4] - Aytu BioPharma, Inc. (AYTU): The stock climbed 8.91% to $2.20, following a prior close of $2.02. The company reported a first-quarter net income of $2.0 million versus $1.5 million a year ago, with revenue of $13.9 million compared to $16.6 million in the prior year [5] - Adicet Bio, Inc. (ACET): The stock added 5.21% to $0.6325, with a reported third-quarter net loss of $12.4 million, slightly wider than last year's $11.6 million. Revenue declined by 16% year-over-year to $6.8 million, but the company reiterated its 2025 revenue guidance [6] - OKYO Pharma Limited (OKYO): The stock rose by 2.44% to $2.18. The CEO is scheduled to present at the Ophthalmology Innovation Summit XV, discussing the investigational drug candidate urcosimod, which has shown promising results in Phase 2 trials [7]